Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer

doi:10.4251/wjgo.v15.i11.1951

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2149)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

1151

Figures (1-9)

191

Tables (1-2)

156

Sum=1569

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

111

Download

406

Sum=517

Nov 15, 2023 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1951-1973
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1951

Full Size Figure Download Figure

Figure 9 Anticancer drug prediction for the risk groups. A to L: Potential drugs for effective antitumor immunotherapy in the high-risk group; M to X: Potential drugs for effective antitumor chemotherapy in the high-risk group. IC₅₀: Half-maximal inhibitory concentration.

Citation: Chen ZH, Lin YL, Chen SQ, Yang XY. Identification of necroptosis-related lncRNAs for prognosis prediction and screening of potential drugs in patients with colorectal cancer. World J Gastrointest Oncol 2023; 15(11): 1951-1973
URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1951.htm
DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1951